|
Volumn 23, Issue 4, 2007, Pages 359-365
|
A comparative, placebo-controlled study of prostanoid fluoroprostaglandin- receptor agonists tafluprost and latanoprost in healthy males
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AFP 168;
LATANOPROST;
PLACEBO;
PROSTAGLANDIN RECEPTOR STIMULATING AGENT;
PROSTANOID RECEPTOR;
TAFLUPROST;
UNCLASSIFIED DRUG;
ANTIHYPERTENSIVE AGENT;
EYE DROPS;
PROSTAGLANDIN F;
PROSTAGLANDIN RECEPTOR;
ADULT;
ARTICLE;
BLURRED VISION;
CHEMOSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIZZINESS;
DRUG SAFETY;
DRUG TOLERABILITY;
DRY EYE;
DRY THROAT;
EPISTAXIS;
EYE IRRITATION;
EYE PAIN;
FATIGUE;
HEADACHE;
HEART PALPITATION;
HUMAN;
HYPEREMIA;
INTRAOCULAR PRESSURE;
KERATITIS;
LACRIMATION;
LIVER DYSFUNCTION;
MALE;
OPTIC DISK ANOMALY;
PHARMACODYNAMICS;
PHOTOPHOBIA;
RANDOMIZED CONTROLLED TRIAL;
RHINOPHARYNGITIS;
SIDE EFFECT;
SNEEZING;
SYNCOPE;
VISUAL ACUITY;
ADOLESCENT;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG EFFECT;
METABOLISM;
MIDDLE AGED;
PHASE 1 CLINICAL TRIAL;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
ADOLESCENT;
ADULT;
ANTIHYPERTENSIVE AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
HYPEREMIA;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
OPHTHALMIC SOLUTIONS;
PHOTOPHOBIA;
PROSTAGLANDINS F;
PROSTAGLANDINS F, SYNTHETIC;
RECEPTORS, PROSTAGLANDIN;
|
EID: 35848961012
PISSN: 10807683
EISSN: None
Source Type: Journal
DOI: 10.1089/jop.2006.0061 Document Type: Article |
Times cited : (46)
|
References (9)
|